You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Litigation Details for LTL Management LLC (Bankr. D.N.J. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Details for LTL Management LLC (Bankr. D.N.J. 2023)

Date FiledDocument No.DescriptionSnippetLink To Document
2023-04-04 External link to document
2023-04-04 855 Exhibit ; 9,181,257; 9,296,753; 9,655,857; 9,725,455; 10,010,507; 10,106,548; and 10,125,140. In June 2019, Pharmacyclics…the Company. Patents The Company’s subsidiaries have made a practice of obtaining patent protection on…of matter patent expires in 2023. The latest expiring European composition of matter patent expires in… has an exclusive license to those patent families. The two patent families both expire in the United …licensed European patent expires in 2032. Janssen Biotech, Inc. owns a separate patent portfolio related External link to document
>Date Filed>Document No.>Description>Snippet>Link To Document
Showing 1 to 2 of 2 entries

LTL Management LLC: A Comprehensive Analysis of the Bankruptcy and Litigation Saga

Introduction

LTL Management LLC, an indirect subsidiary of Johnson & Johnson (J&J), has been at the center of a complex and contentious bankruptcy and litigation process. This article delves into the key aspects of LTL Management's bankruptcy filings, the legal challenges faced, and the implications of the court's decisions.

Background of LTL Management LLC

LTL Management LLC was formed as part of a corporate restructuring of J&J's consumer business. This restructuring, which occurred in 2021, involved the creation of two new entities: LTL Management LLC and Johnson & Johnson Consumer Inc. (New JJCI). LTL assumed all the talc-related liabilities of the former Johnson & Johnson Baby Products Company, a wholly owned subsidiary of J&J[3].

First Chapter 11 Bankruptcy Filing

On October 14, 2021, LTL Management LLC filed its initial voluntary petition for Chapter 11 bankruptcy relief in the United States Bankruptcy Court for the Western District of North Carolina. This filing was part of a strategy to manage the mounting talc-related liabilities, including thousands of ovarian cancer and mesothelioma cases[3].

Funding Agreement and Financial Support

As part of the restructuring, LTL entered into a funding agreement with J&J and New JJCI, which obligated these entities to cover LTL's talc-related liabilities and other costs associated with the bankruptcy case. This agreement provided a significant financial backstop, ensuring that LTL had access to substantial cash holdings and equity interests valued at approximately $30 billion[1][3].

Third Circuit's Dismissal of the First Chapter 11 Case

The Third Circuit Court of Appeals played a crucial role in the litigation. On January 30, 2023, the Third Circuit issued an opinion directing the bankruptcy court to dismiss LTL's first Chapter 11 case. The court ruled that the case was not filed in good faith due to LTL's lack of imminent and immediate financial distress. Despite having significant liabilities, LTL's access to substantial financial resources through the funding agreement meant it was not facing the level of financial distress required for a valid Chapter 11 filing[1][3].

Second Chapter 11 Bankruptcy Filing

Following the dismissal of the first case, LTL Management LLC filed a second Chapter 11 bankruptcy petition on April 4, 2023, just hours after the first case was dismissed. This filing was an attempt to address the same talc-related liabilities and leverage the bankruptcy process to manage these claims[3].

Bankruptcy Court's Decision on the Second Filing

Judge Michael Kaplan of the Bankruptcy Court for the District of New Jersey issued an opinion on July 28, 2023, granting motions to dismiss LTL's second Chapter 11 case. The court found that this second filing was also made in bad faith due to the absence of imminent and immediate financial distress. The decision was consistent with the Third Circuit's earlier ruling, emphasizing that LTL's financial situation, supported by the funding backstop from J&J, did not meet the criteria for a good faith filing under Section 1112(b) of the Bankruptcy Code[1].

Key Legal Issues and Rulings

Good Faith Requirement

A central issue in both bankruptcy cases was whether LTL filed its petitions in good faith. The Third Circuit and the bankruptcy court emphasized that a Chapter 11 petition must serve a valid bankruptcy purpose and not be filed merely to gain a tactical litigation advantage. The courts found that LTL's filings did not meet this standard because the company was not facing imminent financial distress, thanks to its substantial assets and the funding agreement with J&J[1][3].

Imminent Financial Distress

The requirement of imminent and immediate financial distress was a critical factor in the dismissal of both cases. The courts held that LTL's financial situation, despite the significant liabilities, did not demonstrate the necessary level of distress to justify a Chapter 11 filing. This poses a challenge for companies facing future mass tort liabilities who seek to use bankruptcy as a proactive management strategy[1][3].

Funding Agreement and Solvency

The funding agreement with J&J and New JJCI was a pivotal aspect of the cases. The courts recognized that this agreement provided LTL with access to significant financial resources, making it solvent and capable of satisfying its talc-related liabilities without the need for bankruptcy protection[1][3].

Implications and Challenges

Impact on Mass Tort Liability Management

The dismissals highlight the difficulties companies face when trying to manage mass tort liabilities through the bankruptcy process. The Third Circuit's precedent sets a high bar for demonstrating financial distress, which can limit the ability of companies to use Chapter 11 as a tool for managing future liabilities proactively[1].

Corporate Restructuring and Liability Management

The LTL Management LLC cases underscore the importance of careful corporate restructuring and liability management strategies. Companies must ensure that any restructuring or bankruptcy filing aligns with the legal requirements and does not appear to be a tactical maneuver to avoid liabilities[3].

Conclusion

The LTL Management LLC bankruptcy saga is a complex and instructive case that highlights the stringent requirements for filing a Chapter 11 bankruptcy petition in good faith. The decisions by the Third Circuit and the bankruptcy court emphasize the need for imminent and immediate financial distress and the importance of ensuring that bankruptcy filings serve a valid bankruptcy purpose.

Key Takeaways

  • Good Faith Requirement: Chapter 11 petitions must be filed in good faith, serving a valid bankruptcy purpose and not merely to gain a tactical litigation advantage.
  • Imminent Financial Distress: The absence of imminent and immediate financial distress can lead to the dismissal of a Chapter 11 case.
  • Funding Agreements: Significant financial backstops can render a company solvent, making it difficult to justify a bankruptcy filing.
  • Mass Tort Liability Management: The bankruptcy process can be challenging for companies managing mass tort liabilities, especially under the Third Circuit's precedent.
  • Corporate Restructuring: Careful planning and alignment with legal requirements are crucial for corporate restructuring and liability management.

FAQs

What was the primary reason for the dismissal of LTL Management LLC's bankruptcy cases?

The primary reason was the lack of imminent and immediate financial distress, despite facing significant talc-related liabilities.

How did the funding agreement impact LTL Management LLC's bankruptcy filings?

The funding agreement with J&J and New JJCI provided LTL with access to substantial financial resources, making it solvent and capable of satisfying its liabilities without bankruptcy protection.

What is the significance of the Third Circuit's precedent in this case?

The Third Circuit's precedent sets a high bar for demonstrating financial distress, making it challenging for companies to use Chapter 11 as a proactive strategy for managing future mass tort liabilities.

How does this case impact corporate restructuring and liability management?

It highlights the importance of careful planning and ensuring that any restructuring or bankruptcy filing aligns with legal requirements and does not appear to be a tactical maneuver to avoid liabilities.

What are the implications for companies facing mass tort liabilities?

The case underscores the difficulties companies may face in using the bankruptcy process to manage mass tort liabilities proactively, given the stringent requirements for demonstrating financial distress.

Sources

  1. SRZ Alert: "Flames, Not Smoke: LTL Management LLC’s Second Chapter 11 Filing Dismissed by the Bankruptcy Court for the District of New Jersey for Lack of Imminent and Immediate Financial Distress"[1].
  2. GovInfo: "LTL Management, LLC, Plaintiff, v. Those Parties Listed on Appendix A to the Complaint"[2].
  3. FindLaw Caselaw: "IN RE: LTL MANAGEMENT (2023)"[3].
  4. Dow Jones Bankruptcy API: "LTL Management LLC, 3:23-bk-12825, No. 4 (Bankr.D.N.J. Apr. 4, 2023)"[4].
  5. Casetext: "LTL Mgmt. v. Those Parties Listed on Appendix A to the Complaint"[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.